SOURCE: SafeShot Technologies

SafeShot Technologies

September 14, 2010 09:45 ET

SafeShot Technologies Files Patents on New Low-Dose Version of Its Revolutionary Safety Injection Technology Called "Epiphany Ultra"

New Patent Makes SafeShot Technologies the World's First & Only Developer of a Full Line of Safe, Compliant and Affordable Syringe Technology for the Complete Spectrum of Injection Drug Delivery Formats

MISSION VIEJO, CA--(Marketwire - September 14, 2010) -  SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced the successful development and patent filings on a new "low dose" version of its revolutionary safety injection technology called the "Epiphany Ultra." This technology allows for safe injections in 1ml and lower volumes using the same simple, single-handed vacuum retraction technology used in its larger versions. SafeShot Technologies Epiphany and now Epiphany Ultra are the world's first and only available, full line of safe, compliant, simple and affordable technology that works equally well across the full spectrum of desired injection drug delivery needs, including pre-fills, clinical, home, consumer and immunization/vaccination.

The problem of infections and the transfer of blood borne illnesses due to injections have plagued the world for decades, causing needless suffering and deaths and costing the healthcare system an estimated $1.2 billion a year. SafeShot Technologies is focused on designing affordable safety technology to revolutionize the healthcare industry by protecting the nearly 1 million patients and frontline healthcare professionals who are stuck each year in the U.S., while preventing the global spread of HIV/Hepatitis which annually impacts 22 million people.

"This is a huge milestone for our engineering team and company because of the precision required in designing an 'Ultra Low Dose' safety syringe that is as simple and affordable as the Epiphany Ultra," said Robert Beart, Emeritus Professor of Surgery at USC's Keck School of Medicine and CEO of SafeShot. "Epiphany Ultra completes the entire spectrum of safe, compliant injection drug delivery in 'all sizes' while breaking the cost barriers that have prohibited healthcare facilities from broadly adopting the most effective safety technology for their facilities. Its innovative design saves time in training, administering injections, and we are proud to say, it will ultimately saves lives."

The, Needlestick Safety and Prevention Act of 2000 requires healthcare facilities to create, maintain, and annually update information on commercially available technology designed to eliminate or minimize occupational exposure to blood-borne pathogens. Yet many healthcare professionals are still not being equipped with safety solutions to eliminate exposure to blood borne pathogens and sharps injuries.

SafeShot Technologies identified the five key characteristics of a safe, effective and affordable solution to tackle the global issue of needlestick injuries and spread of HIV/Hepatitis from syringe re-use. "Omitting any one of these characteristics in syringe development directly jeopardizes the ability to give a safe shot or eradicate the issues of needlestick injury and syringe re-use," said Michael J. Madden, Safeshot Technologies Board Member and former Vice President of Advocacy and Development for Providence Health & Services. "I've been in the hospital business for a long time, and needlestick injuries have always been an issue for me and for the institutions that I've managed."

The Epiphany Safety Syringe meets all 5 key factors to safe injection drug delivery, including:

  • The device must be "auto disabling" destructing after a single use
  • The device must provide protection from accidental needlesticks
  • The device must be safe through disposal, acting as it's own sharps container
  • The device must not create a blood splatter or aerosol
  • And... the device must be affordable

With the global production of non-safety syringes in the tens of billions, a traditional reusable syringe can be produced for about 10 cents. Primarily due to the higher cost of safety syringes, hospitals have been slow to adopt the latest technology, despite legislation which mandates adoption of the best safety solutions. SafeShot's Epiphany Syringe costs are comparable to a traditional syringe. The issues of accidental needlesticks, re-used needles, downstream injuries and biohazardous waste are directly addressed with this new innovation.

About SafeShot Technologies

SafeShot Technologies, headquartered in Mission Viejo, California, is a new generation safety syringe development company with the mission to solve the needlestick issue with innovative technology. The Epiphany Safety Syringe is the first patented vacuum-triggered, one-handed, single-use, auto-retractable, auto-disable safety syringe designed to provide superior value. SafeShot has more than a dozen U.S. patent applications and foreign counterparts in other major jurisdictions to address this growing problem. For more information on SafeShot Technologies and the Epiphany Safety Syringe, please visit www.SafeShot.net. Click here to follow on Twitter or Facebook.

Contact Information

  • For Additional Information Contact:
    John Sperrazzo
    Eye-To-Eye Communications, Inc.
    858-565-9800
    Email Contact